Psychedelic‐assisted therapy considered ‘breakthrough’ treatment for PTSD

Summary

A groundbreaking therapy is showing profound success in alleviating severe, chronic PTSD. This innovative approach, utilizing psychedelic-assisted sessions, aims to provide lasting relief where traditional treatments often fall short. Promising findings indicate significant symptom reduction, offering new hope. This advancement could pave the way for FDA approval, marking a major step forward in mental health care.

Abstract

New research involving the use of psychedelic‐assisted therapy is showing promise and significant implications for patients with severe, chronic post‐traumatic stress disorder (PTSD) and could potentially move the needle further toward Food and Drug Administration (FDA) approval, say researchers from the Multidisciplinary Association for Psychedelic Studies (MAPS).

Tags